NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration

Date:

Share post:

By Dose Daily News Bureau

20th April, 2026

19:00 PM IST

The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration agreement with Novartis Healthcare Private Limited, marking a significant step towards strengthening industry academic ties in pharmaceutical research. The agreement was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, who stretched the importance of moving such partnerships from pilot stages to scalable impact driven initiatives that addresses genuine healthcare needs.

The partnership brings all 7 NIPER institutes into a unified framework aligned with India’s broader pharmaceutical innovation goals. On 15th April 2026, faculty members collectively submitted 42 research proposals for consideration. Following a rigorous evaluation process one proposal earned the prestigious Development Pioneer grant, recognizing its potential for real-world application and scientific merit.

The initiative is designed to ensure academic research remains application-driven and grounded in clinical relevance, fostering the next generation of pharmaceutical innovators. The signing ceremony was attended by key stakeholders including Avadhesh Kumar Chaudhary, Kini Singh, Dulal Panda, and senior leadership from Novartis.

Written by: Pragna Biswas

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Dabur India Plant Under US FDA Scanner Over Contamination Concerns

The United States Food and Drug Administration (US FDA) has flagged serious concerns at Dabur India's manufacturing facility...

FDA Approves Wockhardt’s Novel Antibiotic ZAYNICH™️ for cUTI

Wockhardt Limited  announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepimeand zidebactam), a novel intravenous antibiotic...

Relief for Patients: NPPA Fixes Ceiling Prices for 30 Essential Medicines

The National Pharmaceutical Pricing Authority (NPPA) has notified ceiling prices for 30 essential fixed-dose combination medicines under the...

FDA Draft Guidance Aims to Reduce Animal Testing for Cancer Drugs

The U.S. Food and Drug Administration (FDA) issued a new draft guidance aimed at reducing unnecessary animal testing...